Rock Springs Capital Management LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.51 Billion distributed in 107 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $141M, Intuitive Surgical Inc with a value of $113M, Eli Lilly & CO with a value of $112M, Neurocrine Biosciences Inc with a value of $98.3M, and Blueprint Medicines Corp with a value of $95.7M.

Examining the 13F form we can see an decrease of $432M in the current position value, from $2.94B to 2.51B.

Rock Springs Capital Management LP is based out at Baltimore, MD

Below you can find more details about Rock Springs Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $2.51 Billion
Healthcare: $2.46 Billion
Consumer Defensive: $48.5 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 107
  • Current Value $2.51 Billion
  • Prior Value $2.94 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 10 stocks
  • Additional Purchases 38 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.